FDA
-
-
-
-
-
-
-
Clearmind completes Part A of FDA-regulated AUD drug trial
-
-
-
-
-
-
-
Clearmind Medicine Reaches Important Clinical Milestone: 20 Participants Now Treated in Ongoing Phase I/IIa Trial of CMND-100 for Alcohol Use Disorder
-
-
-
-
-
-
-
Clearmind Medicine Announced Positive Top-Line Safety Results: CMND-100 Proprietary Psychedelic Treatment Meets Primary Endpoint in AUD Trial
-
-
-
-
-
-
-
Clearmind Medicine Reports Successful Ongoing Treatment of Participants at US Sites in its FDA-approved CMND-100 Phase I/IIa Clinical Trial for Alcohol Use Disorder
-
-
-
-
-
-
-
Moonage Media Review: Clearmind's MEAI and GLP-1 - Are These the Next-Generation Treatment for Weight Loss?
-
-
-
-
-
-
-
Clearmind Medicine advances alcohol disorder drug trial, reports safety data
-
-
-
-
-
-
-
Clearmind Medicine Kicks-Off Patient Enrollment at Tel Aviv Sourasky Medical Center, Adding Another Site Activated in its in Phase I/IIa Alcohol Use Disorder Trial
-
326,710 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

